CALA - Calithera Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CALA is currently covered by 2 analysts with an average price target of $29.35. This is a potential upside of $29.33 (146650%) from yesterday's end of day stock price of $0.02.

Calithera Biosciences's activity chart (see below) currently has 6 price targets and 11 ratings on display. The stock rating distribution of CALA is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.75% with an average time for these price targets to be met of 54 days.

Highest price target for CALA is $7, Lowest price target is $2, average price target is $29.35.

Most recent stock forecast was given by JONATHAN CHANG from LEERINK on 15-Nov-2022. First documented stock forecast 09-Mar-2016.

Best performing analysts who are covering CALA - Calithera Biosciences:

Michael King Jonathan Chang Mohit Bansal Swayampakula Ramakanth

Currently out of the existing stock ratings of CALA, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$1.97 (6566.67%)

2

1 years 6 months 11 days ago

3/4 (75%)

$-0.38 (-15.97%)

53

Buy

8

$7.97 (26566.67%)

1 years 8 months 27 days ago

0/1 (0%)

$4.17 (108.88%)

Buy

140

$139.97 (466566.66%)

4 years 15 days ago

0/2 (0%)

$3.2 (2.34%)

Buy

340

$339.95 (679900.00%)

240

7 years 1 months 27 days ago

3/3 (100%)

$110.33 (71.65%)

163

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CALA (Calithera Biosciences) average time for price targets to be met?

On average it took 54 days on average for the stock forecasts to be realized with a an average price target met ratio 43.75

Which analyst has the current highest performing score on CALA (Calithera Biosciences) with a proven track record?

MICHAEL KING

Which analyst has the current lower performing score on CALA (Calithera Biosciences) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on CALA (Calithera Biosciences)?

Michael King has 5 price targets and 4 ratings on CALA

Which analyst is the currently most bullish on CALA (Calithera Biosciences)?

Michael King with highest potential upside - $339.95

Which analyst is the currently most reserved on CALA (Calithera Biosciences)?

Jonathan Chang with lowest potential downside - $1.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?